Vimarsana
Biggest News Aggregation in the World

Page 10 - Bart Hogan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart Hogan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart Hogan Today - Breaking & Trending Today

Trump warns the market will crash if he loses. Investors just laugh - Vimarsana News

Trump warns the market will crash if he loses. Investors just laugh

Former President Donald Trump is once again warning the stock market is doomed unless voters return him to the White House.

Source: cnn.com
S&P, Dow edge higher, Nvidia market cap exceeds $2 trillion - Vimarsana News

S&P, Dow edge higher, Nvidia market cap exceeds $2 trillion

* Nvidia maintains upward march, achieves $2 trn market cap * Warner Bros Discovery slides after bigger-than-expected loss *...

Amazon set to replace Walgreens in Dow Jones Industrial Average - Vimarsana News

Amazon set to replace Walgreens in Dow Jones Industrial Average

The e-commerce giant’s inclusion in the index is another milestone in the retailer’s rapid expansion in the last decade.

Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost - Vimarsana News

Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost

U.S.-based Eli Lilly and Denmark's Novo Nordisk have struck gold with their weight-loss drugs, sending their shares to stratospheric levels and putting them on par with some high-growth tech stocks. Retail and institutional investors alike have flocked to the two stocks in the past year, as they bet on explosive demand for the companies' obesity drugs, called GLP-1 agonists, in a market that some analysts expect could breach $100 billion. Lilly shares trade 56.17 times the earnings estimates for the next 12 months, while Novo has a price-to-earnings (PE) multiple of 35.84, accordin...

Source: yahoo.com
Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost - Vimarsana News

Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost

U.S.-based Eli Lilly and Denmark's Novo Nordisk have struck gold with their weight-loss drugs, sending their shares to stratospheric levels and putting them on par with some high-growth tech stocks. ...